Empowered Patient Podcast

Welcome to the Empowered Patient Podcast with Karen Jagoda. This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape. Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes Value-based healthcare Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Pan-Cancer AI Platform Providing Academic-Level Precision Medicine to Community Settings with Kristin Ashcraft OncoRx Insights TRANSCRIPT

Download PDF

Mar 11, 2026

Kristin Ashcraft, Co-Founder and CEO of OncoRx Insights, is determined to bring current information to community-based oncologists to help them identify precision therapies for their patients. The AI platform is designed to augment the oncologist's expertise by analyzing molecular diagnostics, pathology reports, and...

Pan-Cancer AI Platform Providing Academic-Level Precision Medicine to Community Settings with Kristin Ashcraft OncoRx Insights

Mar 11, 2026

Testing of Fresh Biopsy Drives Functional Precision Cancer Analysis with Andria Parks First Ascent Biomedical TRANSCRIPT

Download PDF

Mar 9, 2026

Andria Parks, Head of Commercial Operations at First Ascent Biomedical, highlights the value of using a biopsy to grow cancer cells in a lab to determine which drugs are most likely to be effective against a specific cancer. This functional medicine approach combines lab data, genomic data, and AI to produce a report...

Testing of Fresh Biopsy Drives Functional Precision Cancer Analysis with Andria Parks First Ascent Biomedical

Mar 9, 2026

Functional Drug Testing Combined with AI Transforming Cancer Care with Jim Foote First Ascent Biomedical TRANSCRIPT

Download PDF

Dec 2, 2025

Jim Foote, Co-Founder and CEO of First Ascent Biomedical, is changing the standard of care for cancer treatment from 'try and hope' to 'test and treat'. The First Ascent platform combines functional drug testing of fresh biopsies, genomic sequencing, and an AI engine to assess a large panel of drugs and identify the...